- US-listed companies
- BRAINSTORM CELL THERAPEUTICS INC.
- Balance sheet
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Balance sheet
Market cap
$11.03M
P/E ratio
| 2011/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Cash and cash equivalents | 2 | 4 | 4 | 0 | 1 | 2 | 1 | 1 | 38 | 19 | 1 | 1 | 0 | 0 |
| Total cash & short-term investments | 2 | 4 | 4 | 0 | 1 | 2 | 1 | 1 | 38 | 19 | 1 | 1 | 0 | 0 |
| Accounts receivable, net | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total current assets | 2 | 4 | 10 | 17 | 10 | 10 | 10 | 3 | 43 | 23 | 3 | 2 | 0 | 0 |
| Property, plant and equipment, net | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Marketable securities, non-current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - |
| Total non-current assets | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 |
| Total assets | 3 | 5 | 10 | 17 | 11 | 11 | 11 | 7 | 51 | 29 | 8 | 4 | 2 | 1 |
| Accounts payable | 0 | 0 | 2 | 1 | 0 | 1 | 5 | 15 | 5 | 4 | 6 | 5 | 6 | 7 |
| Total current liabilities | 1 | 1 | 3 | 3 | 1 | 6 | 6 | 18 | 11 | 6 | 9 | 8 | 9 | 11 |
| Total non-current liabilities | - | 1 | 0 | - | - | - | - | 1 | 5 | 4 | 3 | 1 | 1 | - |
| Total liabilities | 1 | 2 | 3 | 3 | 1 | 6 | 6 | 19 | 16 | 10 | 11 | 9 | 10 | 11 |
| Retained earnings | - | - | -62 | -70 | -75 | -80 | -94 | -117 | -149 | -174 | -198 | -215 | -227 | -237 |
| Stockholders' equity | 1 | 3 | 7 | 14 | 10 | 6 | 5 | -12 | 35 | 19 | -3 | -5 | -8 | -10 |